Retinal Imaging Techniques for Diabetic Retinopathy Screening

Journal of Diabetes Science and Technology

Volumn 10, Issue 2, 2016, Pages 282-294

  Goh, James Kang Hao ^a,b   Cheung, Carol Y ^c   Sim, Shaun Sebastian ^a   Tan, Pok Chien ^a   Tan, Gavin Siew Wei ^a   Wong, Tien Yin ^a,b,d  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

diabetic retinopathy; imaging; retina; screening

Indexed keywords

ALGORITHM; COST EFFECTIVENESS ANALYSIS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE SEVERITY; HEALTH CARE COST; HUMAN; IMAGE ANALYSIS; MYDRIASIS; OPTICAL COHERENCE TOMOGRAPHY; OXYGEN SATURATION; PHOTOGRAPHY; PRIMARY HEALTH CARE; REVIEW; SCANNING LASER OPHTHALMOSCOPY; SCREENING; SENSITIVITY ANALYSIS; TELEMEDICINE; DIAGNOSTIC IMAGING; FEMALE; MALE; MASS SCREENING; PROCEDURES; VISUAL SYSTEM EXAMINATION;

DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; MALE; MASS SCREENING;

EID: 85009270970     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296816629491     Document Type: Review

References (142)

1. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301 (20): 2129-2140.
2. Congdon NG, Friedman DS, Lietman T,. Important causes of visual impairment in the world today. JAMA. 2003; 290 (15): 2057-2060.
3. Cheung N, Mitchell P, Wong TY,. Diabetic retinopathy. Lancet. 2010; 376 (9735): 124-136.
4. Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Global Health. 2013; 1 (6): e339-e349.
5. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35 (3): 556-564.
6. Rohan TE, Frost CD, Wald NJ,. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ. 1989; 299 (6709): 1198-1201.
7. Ferris FL III,. How effective are treatments for diabetic retinopathy? JAMA. 1993; 269 (10): 1290-1291.
8. Kiire CA, Porta M, Chong V,. Medical management for the prevention and treatment of diabetic macular edema. Surv Ophthalmol. 2013; 58 (5): 459-465.
9. Pershing S, Enns EA, Matesic B, Owens DK, Goldhaber-Fiebert JD,. Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med. 2014; 160 (1): 18-29.
10. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007; 125 (4): 469-480.
11. Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015; 372 (13): 1193-1203.
12. Wells JA, Glassman AR, Jampol LM, et al. Association of baseline visual acuity and retinal thickness with 1-year efficacy of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema [published online ahead of print November 25, 2015]. JAMA Ophthalmol.
13. Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015; 314 (20): 2137-2146.
14. Kroenke K,. Telemedicine screening for eye disease. JAMA. 2015; 313 (16): 1666-1667.
15. Chasan JE, Delaune B, Maa AY, Lynch MG,. Effect of a teleretinal screening program on eye care use and resources. JAMA Ophthalmol. 2014; 132 (9): 1045-1051.
16. Mohamed Q, Gillies MC, Wong TY,. Management of diabetic retinopathy: a systematic review. JAMA. 2007; 298 (8): 902-916.
17. Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR,. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology. 2004; 111 (5): 1055-1062.
18. Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR,. Screening for presence or absence of diabetic retinopathy: a meta-analysis. Arch Ophthalmol. 2010; 129 (4): 435-444.
19. National Institute for Clinical Excellence. Management of Type 2 Diabetes: Retinopathy-Screening and Early Management. London, UK: Inherited Clinical Guideline; 2002.
20. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98 (5 suppl): 786-806.
21. Rudnisky CJ, Hinz BJ, Tennant MT, de Leon AR, Greve MD,. High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. Ophthalmology. 2002; 109 (2): 267-274.
22. Cavallerano JD, Aiello LP, Cavallerano AA, et al. Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mild diabetic retinopathy. Am J Ophthalmol. 2005; 140 (4): 667-673.
23. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol. 2004; 88 (7): 920-924.
24. Ting DS, Tay-Kearney ML, Kanagasingam Y,. Light and portable novel device for diabetic retinopathy screening. Clin Experiment Ophthalmol. 2012; 40 (1): e40-e46.
25. Vujosevic S, Benetti E, Massignan F, et al. Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol. 2009; 148 (1): 111-118.
26. Aptel F, Denis P, Rouberol F, Thivolet C,. Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabetes Metab. 2008; 34 (3): 290-293.
27. Pugh JA, Jacobson JM, Van Heuven WA, et al. Screening for diabetic retinopathy. The wide-angle retinal camera. Diabetes Care. 1993; 16 (6): 889-895.
28. Ku JJ, Landers J, Henderson T, Craig JE,. The reliability of single-field fundus photography in screening for diabetic retinopathy: the Central Australian Ocular Health Study. Med J Australia. 2013; 198 (2): 93-96.
29. Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM,. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002; 134 (2): 204-213.
30. Olson JA, Strachan FM, Hipwell JH, et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med. 2003; 20 (7): 528-534.
31. Boucher MC, Gresset JA, Angioi K, Olivier S,. Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields. Can J Ophthalmol. 2003; 38 (7): 557-568.
32. Hutchinson A, McIntosh A, Peters J, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy-a systematic review. Diabet Med. 2000; 17 (7): 495-506.
33. Liew G, Mitchell P, Wang JJ, Wong TY,. Fundoscopy: to dilate or not to dilate? BMJ. 2006; 332 (7532): 3.
34. Fransen SR, Leonard-Martin TC, Feuer WJ, Hildebrand PL, Inoveon Health Research Group. Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology. 2002; 109 (3): 595-601.
35. Facey K, Cummins E, Macpherson K,. Organisation of Services for Diabetic Retinopathy Screening. Health Technology Assessment Report 1. Glasgow, UK: Health Technology Board for Scotland; 2002.
36. Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol. 2015; 99 (1): 64-68.
37. Ryder RE,. Screening for diabetic retinopathy in the 21st century. Diabet Med. 1998; 15 (9): 721-722.
38. Fransen SR, Leonard-Martin TC, Feuer WJ, Hildebrand PL,. Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology. 2002; 109 (3): 595-601.
39. Gangaputra S, Almukhtar T, Glassman AR, et al. Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. Invest Ophthalmol Vis Sci. 2011; 52 (9): 6168-6173.
40. Romero-Aroca P, Sagarra-Alamo R, Pareja-Rios A, Lopez M,. Importance of telemedicine in diabetes care: Relationships between family physicians and ophthalmologists. World J Diabetes. 2015; 6 (8): 1005-1008.
41. Garg S, Jani PD, Kshirsagar AV, King B, Chaum E,. Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med. 2012; 172 (21): 1677-1678.
42. Shi L, Wu H, Dong J, Jiang K, Lu X, Shi J,. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol. 2015; 99 (6): 823-831.
43. Owsley C, McGwin G Jr, Lee DJ, et al. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015; 133 (2): 174-181.
44. Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD,. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology. 2013; 120 (12): 2604-2610.
45. Ikram MK, Cheung CY, Lorenzi M, et al. Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes Care. 2013; 36 (3): 750-759.
46. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ,. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia. 2011; 54 (9): 2409-2416.
47. Broe R, Rasmussen ML, Frydkjaer-Olsen U, et al. Retinal vascular fractals predict long-term microvascular complications in type 1 diabetes mellitus: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987). Diabetologia. 2014; 57 (10): 2215-2221.
48. Tsai AS, Wong TY, Lavanya R, et al. Differential association of retinal arteriolar and venular caliber with diabetes and retinopathy. Diabetes Res Clin Pract. 2011; 94 (2): 291-298.
49. Cheung CY, Lamoureux E, Ikram MK, et al. Retinal vascular geometry in Asian persons with diabetes and retinopathy. J Diabetes Sci Technol. 2012; 6 (3): 595-605.
50. Ding J, Ikram MK, Cheung CY, Wong TY,. Retinal vascular calibre as a predictor of incidence and progression of diabetic retinopathy. Clin Exp Optom. 2012; 95 (3): 290-296.
51. Sim DA, Keane PA, Tufail A, Egan CA, Aiello LP, Silva PS,. Automated retinal image analysis for diabetic retinopathy in telemedicine. Curr Diab Rep. 2015; 15 (3): 14.
52. Wu H, Zhang X, Geng X, Dong J, Zhou G,. Computer aided quantification for retinal lesions in patients with moderate and severe non-proliferative diabetic retinopathy: a retrospective cohort study. BMC Ophthalmol. 2014; 14: 126.
53. Philip S, Fleming AD, Goatman KA, et al. The efficacy of automated "disease/no disease" grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol. 2007; 91 (11): 1512-1517.
54. Haritoglou C, Kernt M, Neubauer A, et al. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy. Retina. 2014; 34 (1): 157-164.
55. Chaum E, Karnowski TP, Govindasamy VP, Abdelrahman M, Tobin KW,. Automated diagnosis of retinopathy by content-based image retrieval. Retina. 2008; 28 (10): 1463-1477.
56. Niemeijer M, van Ginneken B, Russell SR, Suttorp-Schulten MS, Abramoff MD,. Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis. Invest Ophthalmol Vis Sci. 2007; 48 (5): 2260-2267.
57. Hansen AB, Hartvig NV, Jensen MS, Borch-Johnsen K, Lund-Andersen H, Larsen M,. Diabetic retinopathy screening using digital non-mydriatic fundus photography and automated image analysis. Acta Ophthalmol Scand. 2004; 82 (6): 666-672.
58. Solanki K, Ramachandra C, Bhat S, Bhaskaranand M, Nittala MG, Sadda SR,. EyeArt: automated, high-throughput, image analysis for diabetic retinopathy screening. Invest Ophthamol Vis Sci. 2015; 56 (7): 1429-1429.
59. Tan PC, Cheung CYL, Lamoureux E, Hsu W, Lee ML, Wong TY,. Cloud-based imaging program for diabetic retinopathy screening and monitoring [ARVO abstract]. Invest Ophthamol Vis Sci. 2015; 56 (7): 1430-1430.
60. VisionQuest Biomedical. DR-RACS™. DR Screening and Image Quality 2015. Available at: http://visionquest-bio.com. Accessed August 31, 2015.
61. Ribeiro ML, Nunes SG, Cunha-Vaz JG,. Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. Diabetes Care. 2013; 36 (5): 1254-1259.
62. Pires R, Jelinek HF, Wainer J, Valle E, Rocha A,. Advancing bag-of-visual-words representations for lesion classification in retinal images. PLOS ONE. 2014; 9 (6): e96814.
63. Usman Akram M, Khalid S, Tariq A, Khan SA, Azam F,. Detection and classification of retinal lesions for grading of diabetic retinopathy. Comput Biol Med. 2014; 45: 161-171.
64. Hassan SS, Bong DB, Premsenthil M,. Detection of neovascularization in diabetic retinopathy. J Digital Imaging. 2012; 25 (3): 437-444.
65. Lee J, Zee BC, Li Q,. Detection of neovascularization based on fractal and texture analysis with interaction effects in diabetic retinopathy. PLOS ONE. 2013; 8 (12): e75699.
66. Scotland GS, McNamee P, Philip S, et al. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol. 2007; 91 (11): 1518-1523.
67. Fleming AD, Goatman KA, Philip S, Prescott GJ, Sharp PF, Olson JA,. Automated grading for diabetic retinopathy: a large-scale audit using arbitration by clinical experts. Br J Ophthalmol. 2010; 94 (12): 1606-1610.
68. Scotland GS, McNamee P, Fleming AD, et al. Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy. Br J Ophthalmol. 2010; 94 (6): 712-719.
69. Drexler W, Fujimoto JG,. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res. 2008; 27 (1): 45-88.
70. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991; 254 (5035): 1178-1181.
71. Costa RA, Skaf M, Melo LA Jr, et al. Retinal assessment using optical coherence tomography. Prog Retin Eye Res. 2006; 25 (3): 325-353.
72. Stanga PE, Bird AC,. Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. Int Ophthalmol. 2001; 23 (4-6): 191-197.
73. Schaudig UH, Glaefke C, Scholz F, Richard G,. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers. 2000; 31 (3): 182-186.
74. Oshitari T, Hanawa K, Adachi-Usami E,. Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye (Lond). 2009; 23 (4): 884-889.
75. Asefzadeh B, Fisch BM, Parenteau CE, Cavallerano AA,. Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy. Clin Experiment Ophthalmol. 2008; 36 (5): 455-463.
76. Goebel W, Kretzchmar-Gross T,. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina. 2002; 22 (6): 759-767.
77. Bressler NM, Edwards AR, Antoszyk AN, et al. Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol. 2008; 145 (5): 894-901.
78. Diabetic Retinopathy Clinical Research Network, Bressler NM, Miller KM, et al. Observational study of subclinical diabetic macular edema. Eye (Lond). 2012; 26 (6): 833-840.
79. Krzystolik MG, Strauber SF, Aiello LP, et al. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology. 2007; 114 (8): 1520-1525.
80. Browning DJ, Glassman AR, Aiello LP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008; 115 (8): 1366-1371, 1371 e1361.
81. Massin P, Girach A, Erginay A, Gaudric A,. Optical coherence tomography: a key to the future management of patients with diabetic macular oedema. Acta Ophthalmol Scand. 2006; 84 (4): 466-474.
82. Chan A, Duker JS,. A standardized method for reporting changes in macular thickening using optical coherence tomography. Arch Ophthalmol. 2005; 123 (7): 939-943.
83. Virgili G, Menchini F, Murro V, Peluso E, Rosa F, Casazza G,. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2011 (7): CD008081.
84. Virgili G, Menchini F, Casazza G, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015; 1: CD008081.
85. Glassman AR, Beck RW, Browning DJ, Danis RP, Kollman C, Diabetic Retinopathy Clinical Research Network Study Group. Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. Invest Ophthalmol Vis Sci. 2009; 50 (2): 560-566.
86. Davis MD, Bressler SB, Aiello LP, et al. Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci. 2008; 49 (5): 1745-1752.
87. Dodson P, Quany L, Leigh R, Wharton H,. Ophthalmic Photographic Diabetic Review (OPDR): a virtual clinic approach for management of referable diabetic maculopathy, 2012. Available at: http://www.retinalscreening.co.uk/wp-content/uploads/2015/06/OPDR-poster.pdf. Accessed August 31, 2015.
88. Manjunath V, Papastavrou V, Steel DH, et al. Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening. Eye (Lond). 2015; 29 (3): 416-423.
89. Lee CS, Lee AY, Sim DA, et al. Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. Am J Ophthalmol. 2015; 159 (1): 101-110 e101.
90. Prescott G, Sharp P, Goatman K, et al. Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study. Br J Ophthalmol. 2014; 98 (8): 1042-1049.
91. Olson J, Sharp P, Goatman K, et al. Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol Assess. 2013; 17 (51): 1-142.
92. Kanji A, Jojo V, Schmermer S, Connor C, SS M,. Managing patients with early diabetic maculopathy via virtual SD-OCT clinics. Diabetic Eye J. 2015;: 34-38. Available at: http://www.eyescreening.org.uk/userFiles/File/DiabeticEyeJournal/DEJ4-1a.pdf
93. Shelton RL, Jung W, Sayegh SI, McCormick DT, Kim J, Boppart SA,. Optical coherence tomography for advanced screening in the primary care office. J Biophotonics. 2014; 7 (7): 525-533.
94. Oshitari T, Mitamura Y,. Optical coherence tomography for complete management of patients with diabetic retinopathy. Curr Diabetes Rev. 2010; 6 (4): 207-214.
95. Cunha-Vaz J, Ribeiro L, Lobo C,. Phenotypes and biomarkers of diabetic retinopathy. Prog Retin Eye Res. 2014; 41: 90-111.
96. Elhabashy SA, Elbarbary NS, Nageb KM, Mohammed MM,. Can optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre study. J Pediatr Endocrinol Metab. 2015; 28 (1-2): 139-146.
97. Trinavarat A, Pituksung A,. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: a randomized controlled trial. Indian J Ophthalmol. 2009; 57 (5): 351-354.
98. Soliman AZ, Silva PS, Aiello LP, Sun JK,. Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy. Semin Ophthalmol. 2012; 27 (5-6): 221-227.
99. Silva PS, Cavallerano JD, Tolls D, et al. Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program. Diabetes Care. 2014; 37 (1): 50-55.
100. Silva PS, Cavallerano JD, Tolson AM, et al. Real-time ultrawide field image evaluation of retinopathy in a diabetes telemedicine program. Diabetes Care. 2015; 38 (9): 1643-1649.
101. Rasmussen ML, Broe R, Frydkjaer-Olsen U, et al. Comparison between Early Treatment Diabetic Retinopathy Study 7-field retinal photos and non-mydriatic, mydriatic and mydriatic steered widefield scanning laser ophthalmoscopy for assessment of diabetic retinopathy. J Diabetes Complications. 2015; 29 (1): 99-104.
102. Kiss S, Berenberg TL,. Ultra widefield fundus imaging for diabetic retinopathy. Curr Diab Rep. 2014; 14 (8): 514.
103. Kernt M, Hadi I, Pinter F, et al. Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care. 2012; 35 (12): 2459-2463.
104. Silva PS, Cavallerano JD, Sun JK, Noble J, Aiello LM, Aiello LP,. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol. 2012; 154 (3): 549-559 e542.
105. Price LD, Au S, Chong NV,. Optomap ultrawide field imaging identifies additional retinal abnormalities in patients with diabetic retinopathy. Clin Ophthalmol. 2015; 9: 527-531.
106. Etten PGv, Brouwere DD, Westers P, Ciriano JPM,. Zero dilation ophthalmoscopy. J Ophthalmic Photography. 2014; 36 (2): 55-62.
107. Yogesan K, Constable IJ, Barry CJ, Eikelboom RH, McAllister IL, Tay-Kearney ML,. Telemedicine screening of diabetic retinopathy using a hand-held fundus camera. Telemedicine J. 2000; 6 (2): 219-223.
108. Querques G, Lattanzio R, Querques L, et al. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci. 2012; 53 (10): 6017-6024.
109. Xu J, Xu L, Du KF, et al. Subfoveal choroidal thickness in diabetes and diabetic retinopathy. Ophthalmology. 2013; 120 (10): 2023-2028.
110. Rayess N, Rahimy E, Ying GS, et al. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol. 2015; 159 (1): 85-91 e81-83.
111. Adhi M, Badaro E, Liu JJ, et al. Three-dimensional enhanced imaging of vitreoretinal interface in diabetic retinopathy using swept-source optical coherence tomography. Am J Ophthalmol. 2016; 162: 140-149.e1.
112. Yoshitake S, Murakami T, Uji A, et al. Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema. Eye (Lond). 2015; 29 (5): 662-669.
113. Makita S, Hong Y, Yamanari M, Yatagai T, Yasuno Y,. Optical coherence angiography. Opt Express. 2006; 14 (17): 7821-7840.
114. Wang RK, Jacques SL, Ma Z, Hurst S, Hanson SR, Gruber A,. Three dimensional optical angiography. Opt Express. 2007; 15 (7): 4083-4097.
115. Yasuno Y, Hong Y, Makita S, et al. In vivo high-contrast imaging of deep posterior eye by 1-microm swept source optical coherence tomography and scattering optical coherence angiography. Opt Express. 2007; 15 (10): 6121-6139.
116. Moult E, Choi W, Waheed NK, et al. Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina. 2014; 45 (6): 496-505.
117. Thorell MR, Zhang Q, Huang Y, et al. Swept-source OCT angiography of macular telangiectasia type 2. Ophthalmic Surg Lasers Imaging Retina. 2014; 45 (5): 369-380.
118. Huang Y, Zhang Q, Thorell MR, et al. Swept-source OCT angiography of the retinal vasculature using intensity differentiation-based optical microangiography algorithms. Ophthalmic Surg Lasers Imaging Retina. 2014; 45 (5): 382-389.
119. Lee JC, Wong BJ, Tan O, et al. Pilot study of Doppler optical coherence tomography of retinal blood flow following laser photocoagulation in poorly controlled diabetic patients. Invest Ophthalmol Vis Sci. 2013; 54 (9): 6104-6111.
120. Wang Y, Fawzi A, Tan O, Gil-Flamer J, Huang D,. Retinal blood flow detection in diabetic patients by Doppler Fourier domain optical coherence tomography. Opt Express. 2009; 17 (5): 4061-4073.
121. Miura M, Hong YJ, Yasuno Y, Muramatsu D, Iwasaki T, Goto H,. Three-dimensional vascular imaging of proliferative diabetic retinopathy by Doppler optical coherence tomography. Am J Ophthalmol. 2014; 159 (3): 528-538 e523.
122. Kim JE, Chung M,. Adaptive optics for retinal imaging: current status. Retina. 2013; 33 (8): 1483-1486.
123. An L, Shen TT, Wang RK,. Using ultrahigh sensitive optical microangiography to achieve comprehensive depth resolved microvasculature mapping for human retina. J Biomed Optics. 2011; 16 (10): 106013.
124. Nelson DA, Burgansky-Eliash Z, Barash H, et al. High-resolution wide-field imaging of perfused capillaries without the use of contrast agent. Clin Ophthalmol. 2011; 5: 1095-1106.
125. Rha J, Jonnal RS, Thorn KE, Qu J, Zhang Y, Miller DT,. Adaptive optics flood-illumination camera for high speed retinal imaging. Opt Express. 2006; 14 (10): 4552-4569.
126. Roorda A, Romero-Borja F, Donnelly III W, Queener H, Hebert T, Campbell M,. Adaptive optics scanning laser ophthalmoscopy. Opt Express. 2002; 10 (9): 405-412.
127. Zawadzki RJ, Cense B, Zhang Y, Choi SS, Miller DT, Werner JS,. Ultrahigh-resolution optical coherence tomography with monochromatic and chromatic aberration correction. Opt Express. 2008; 16 (11): 8126-8143.
128. Wang Q, Kocaoglu OP, Cense B, et al. Imaging retinal capillaries using ultrahigh-resolution optical coherence tomography and adaptive optics. Invest Ophthalmol Vis Sci. 2011; 52 (9): 6292-6299.
129. Lombardo M, Parravano M, Serrao S, Ducoli P, Stirpe M, Lombardo G,. Analysis of retinal capillaries in patients with type 1 diabetes and nonproliferative diabetic retinopathy using adaptive optics imaging. Retina. 2013; 33 (8): 1630-1639.
130. Lombardo M, Serrao S, Devaney N, Parravano M, Lombardo G,. Adaptive optics technology for high-resolution retinal imaging. Sensors. 2013; 13 (1): 334-366.
131. Tam J, Dhamdhere KP, Tiruveedhula P, et al. Disruption of the retinal parafoveal capillary network in type 2 diabetes before the onset of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2011; 52 (12): 9257-9266.
132. Burns SA, Elsner AE, Chui TY, et al. In vivo adaptive optics microvascular imaging in diabetic patients without clinically severe diabetic retinopathy. Biomed Opt Express. 2014; 5 (3): 961-974.
133. Bek T,. Fine structure in diabetic retinopathy lesions as observed by adaptive optics imaging. A qualitative study. Acta Ophthalmologica. 2014; 92 (8): 753-758.
134. Burgansky-Eliash Z, Nelson DA, Bar-Tal OP, Lowenstein A, Grinvald A, Barak A,. Reduced retinal blood flow velocity in diabetic retinopathy. Retina. 2010; 30 (5): 765-773.
135. Burgansky-Eliash Z, Barak A, Barash H, et al. Increased retinal blood flow velocity in patients with early diabetes mellitus. Retina. 2011; 32 (1): 112-119.
136. Nelson DA, Krupsky S, Pollack A, et al. Special report: Noninvasive multi-parameter functional optical imaging of the eye. Ophthalmic Surg Lasers Imaging. 2005; 36 (1): 57-66.
137. OcuSciences. OcuMet Beacon. 2015. Available at: http://www.ocumet.com/. Accessed August 25, 2015.
138. Field MG, Elner VM, Puro DG, et al. Rapid, noninvasive detection of diabetes-induced retinal metabolic stress. Arch Ophthalmol. 2008; 126 (7): 934-938.
139. Khoobehi B, Firn K, Thompson H, Reinoso M, Beach J,. Retinal arterial and venous oxygen saturation is altered in diabetic patients. Invest Ophthalmol Vis Sci. 2013; 54 (10): 7103-7106.
140. Jorgensen CM, Hardarson SH, Bek T,. The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy. Acta Ophthalmologica. 2014; 92 (1): 34-39.
141. Man RE, Sasongko MB, Xie J, et al. Associations of retinal oximetry in persons with diabetes. Clin Experiment Ophthalmol. 2015; 43 (2): 124-131.
142. Cunha-Vaz J, Faria de, Abreu JR, Campos AJ,. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol. 1975; 59 (11): 649-656.